Funding for this research was provided by:
National Institute for Health Research
Article History
Received: 24 July 2018
Accepted: 4 January 2019
First Online: 15 January 2019
Ethics approval and consent to participate
: Ethical approval for this study has been given by the Westminster Research Ethics Committee, ref: 17/LO/0831. Participants will be asked to give written informed consent by a researcher after being given time to read the patient information sheet and being given time to ask any questions.
: Not applicable
: NS is the director of London Safety and Training Solutions Ltd, which provides training and advisory services to healthcare organisations and training programmes globally. FG has received support or honoraria for CME, has advisory work and lectures from Bristol-Myers Squibb, Janssen, Lundbeck, Otsuka, Roche, and Sunovion, and has a family member with professional links to Lilly and GSK, including shares. FG is in part funded by the National Institute for Health Research’s (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, by the South London Collaboration for Leadership in Applied Health Research and Care Funding scheme, and by the Maudsley Charity.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.